The Novel COVID-19 Infections in Iran: Management and Challenges
Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 124
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_EBHPME-4-4_001
تاریخ نمایه سازی: 20 دی 1399
Abstract:
The novel coronavirus (COVID-19) was first identified in Wuhan, China, in December 2019 among a cluster of patients that presented with an unidentified form of viral pneumonia with a shared history of visiting the Huanan seafood market. The pathogen has been identified as a novel enveloped RNA Betacoronavirus that has currently been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has a phylogenetic similarity to SARS-CoV. The World Health Organization (WHO) declared coronavirus disease 2019 (Covid-19), caused by SARS-COV2, is a public health emergency of international concern which is a threat to all countries including Iran.
Keywords:
Authors
Shiva Kargar
Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran
Mostafa Peyvand
Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran
Fateme Hajizadeh
Boshehr University of Medical Sciences, Boshehr, Iran